Generic Name: Glycopyrronium bromide
Brand Name: Seebri
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Therapeutic Area: Chronic obstructive pulmonary disease
Indications: Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: May 15, 2013
Recommendation Type: List with criteria/condition